O 6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma : Implications for Treatment with Alkylating Agents 1
暂无分享,去创建一个
M. Dolan | T. Kuzel | J. Guitart | D. Yarosh | E. Ferries-Rowe | B. Mcrae | M. Belanich | D. Pezen | G. Seventer | G. Seventer
[1] J. Herman,et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.
[2] T. Brent,et al. Methylation of selected CpGs in the human O6‐methylguanine‐DNA methyltransferase promoter region as a marker of gene silencing , 1999, Molecular carcinogenesis.
[3] P. Goodfellow,et al. A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers , 1999, Molecular carcinogenesis.
[4] M. Roddie,et al. Phase I trial of temozolomide using an extended continuous oral schedule. , 1998, Cancer research.
[5] H. Eyre,et al. Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] C. Ramana,et al. Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling. , 1998, Cancer research.
[7] W. Jurecka,et al. Longterm remission of tumor-stage mycosis fungoides following total-skin electron-beam radiotherapy. , 1998, European journal of dermatology : EJD.
[8] T. Fitzpatrick,et al. The benefits and risks of long-term PUVA photochemotherapy. , 1998, Dermatologic clinics.
[9] M. Berger,et al. O6-methylguanine-DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics. , 1998, Cancer research.
[10] R. Pieper,et al. Aberrant silencing of the CpG island-containing human O6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning , 1997, Molecular and cellular biology.
[11] T. Brent,et al. Methylation hot spots in the 5' flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene. , 1997, Cancer research.
[12] L. Wilson,et al. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). , 1997, International journal of radiation oncology, biology, physics.
[13] D. Cooper,et al. Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-->AT transition in the K-ras oncogene. , 1997, Carcinogenesis.
[14] M. Dolan,et al. O6-benzylguanine and its role in chemotherapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] L. Wilson,et al. Mycosis fungoides and total skin electron beam radiation. , 1997, Blood.
[16] A. Watson. Photochemotherapy for mycosis fungoides: Current status * , 1997, The Australasian journal of dermatology.
[17] C. Kjellström,et al. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread. , 1996, Acta dermato-venereologica.
[18] M. Prados,et al. Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. , 1996, Cancer research.
[19] D. Ramsay,et al. Topical treatment of early cutaneous T-cell lymphoma. , 1995, Hematology/oncology clinics of North America.
[20] S. Shaw,et al. Immunomagnetic Purification of T Cell Subpopulations , 1995, Current protocols in immunology.
[21] J. Willson,et al. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance. , 1995, Hematology/oncology clinics of North America.
[22] G. Wani,et al. Differential expression of the o6‐alkylguanine‐DNA alkyltransferase gene in normal human breast and skin tissue: In situ mapping of cell type‐specific expression , 1995, Molecular carcinogenesis.
[23] L. Golitz,et al. Systemic Therapy of Cutaneous T-Cell Lymphomas (Mycosis Fungoides and the Sezary Syndrome) , 1994, Annals of Internal Medicine.
[24] H S Zackheim,et al. Treatment of cutaneous T-cell lymphoma. , 1994, Seminars in dermatology.
[25] H. Zackheim. Topical carmustine (BCNU) for patch/plaque mycosis fungoides. , 1994, Seminars in dermatology.
[26] M. Berger,et al. Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. , 1993, Cancer research.
[27] E. Newlands,et al. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. , 1993, British Journal of Cancer.
[28] G. Wood,et al. Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment , 1993, CA: a cancer journal for clinicians.
[29] S. Culine,et al. Overexpression of the ras-related rab2 gene product in peripheral blood mononuclear cells from patients with hematological and solid neoplasms. , 1992, Cancer research.
[30] C. Quarterman,et al. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). , 1992, British Journal of Cancer.
[31] A. Tosca,et al. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides. , 1991, Anticancer research.
[32] T. Kuzel,et al. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] T. Kuzel,et al. Cutaneous T-cell lymphoma. , 1991, Oncology nursing forum.
[34] D. Ludlum. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. , 1990, Mutation research.
[35] S. Belinsky,et al. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. , 1989, Cancer research.
[36] E. Sausville,et al. Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system. , 1985, Human pathology.
[37] J. Antolak,et al. Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides. , 1998, International journal of radiation oncology, biology, physics.
[38] C. Weghorst,et al. Molecular characterization of mutations in the hprt gene of normal human skin keratinocytes treated with N‐ethyl‐N‐nitrosourea: Influence of O6‐alkylguanine alkyltransferase , 1997, Environmental and molecular mutagenesis.
[39] D. Ludlum. The chloroethylnitrosoureas: sensitivity and resistance to cancer chemotherapy at the molecular level. , 1997, Cancer investigation.
[40] J. Allay,et al. Role of DNA repair in resistance to drugs that alkylate O6 of guanine. , 1996, Cancer treatment and research.
[41] M. Citron,et al. Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase , 1996, Cancer Chemotherapy and Pharmacology.
[42] M. Dolan,et al. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. , 1995, Progress in nucleic acid research and molecular biology.